18F-FDG and 68Ga-DOTATOC PET/CT Findings in a Case of Abdominal Leiomyosarcoma.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 May 2021
01 May 2021
Historique:
pubmed:
17
12
2020
medline:
30
4
2021
entrez:
16
12
2020
Statut:
ppublish
Résumé
We report the case of a 58-year-old man with mesenteric nodule at CT performed for abdominal pain. In the suspicion of neoplastic disease, he underwent 18F-FDG PET/CT that did not show abnormal uptake. The nodule was monitored alternating CT and MRI. Two years after the first detection, MRI revealed an increase in size, and 18F-FDG PET/CT was repeated for metabolic evaluation, showing increased metabolic activity. In suspicion of neuroendocrine tumor, for anatomical site, slow growth, and clinical symptoms, 68Ga-DOTATOC PET/CT was performed showing focal uptake, indicating high expression of somatostatin receptors. The final pathology report was consistent with high-grade leiomyosarcoma.
Identifiants
pubmed: 33323743
pii: 00003072-202105000-00032
doi: 10.1097/RLU.0000000000003474
doi:
Substances chimiques
Organometallic Compounds
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
gallium Ga 68 dotatate
9L17Y0H71P
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e270-e272Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Volante M, Brizzi MP, Faggiano A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol . 2007;20:1172–1182.
Reubi JC, Waser B, Laissue JA, et al. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res . 1996;56:1922–1931.
Boulagnon-Rombi C, Fleury C, Fichel C, et al. Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics. J Neuropathol Exp Neurol . 2017;76:289–298.
Park JY, Lee JW, Lee HJ, et al. Prognostic significance of preoperative 18 F-FDG PET/CT in uterine leiomyosarcoma. J Gynecol Oncol . 2017;28:e28.
Lee J-W, Park J-Y, Lee HJ, et al. Preoperative [ 18 F]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study. Eur J Nucl Med Mol Imaging . 2018;45:1309–1316.
Calcagni ML, Mattoli MV, Blasi MA, et al. A prospective analysis of 18 F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features. Eur J Nucl Med Mol Imaging . 2013;40:1682–1691.
Florio T, Montella L, Corsaro A, et al. In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors. Anticancer Res . 2003;23:2465–2471.
Tao LL, Huang YH, Chen YL, et al. SSTR2a is a useful diagnostic marker for follicular dendritic cells and their related tumors. Am J Surg Pathol . 2019;43:374–381.
Palmieri G, Montella L, Aiello C, et al. Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract. Amino Acids . 2007;32:395–400.
Long M, Shao F, Lan X. Mediastinal epithelioid hemangioendothelioma revealed on 68 Ga-DOTATATE PET/CT. Clin Nucl Med . 2020;45:414–416.